[
  {
    "ts": null,
    "headline": "Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs",
    "summary": "Regeneron Chief Scientific Officer George Yancopoulos joins Bloomberg's Katie Greifeld at the annual JP Morgan healthcare conference in San Francisco to talk about the FDA's response to their hearing loss gene therapy as well as their plans to roll out weight loss drugs.",
    "url": "https://finnhub.io/api/news?id=84949242d252f0205e9dbe866b7d2538801773302d7687ee758d5051c70e0207",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768335755,
      "headline": "Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs",
      "id": 138093473,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Chief Scientific Officer George Yancopoulos joins Bloomberg's Katie Greifeld at the annual JP Morgan healthcare conference in San Francisco to talk about the FDA's response to their hearing loss gene therapy as well as their plans to roll out weight loss drugs.",
      "url": "https://finnhub.io/api/news?id=84949242d252f0205e9dbe866b7d2538801773302d7687ee758d5051c70e0207"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Signs US Deal to Cut Drug Prices, Secure Tariff Exemptions",
    "summary": "AbbVie agreed to lower Medicaid prices and invest $100 billion in the US in exchange for tariff and pricing relief.",
    "url": "https://finnhub.io/api/news?id=e4ef8cd34086e88cd30402d138b3fc81c31b1f0708cc23371f7f454d9d73e900",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768327047,
      "headline": "AbbVie Signs US Deal to Cut Drug Prices, Secure Tariff Exemptions",
      "id": 138086665,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "AbbVie agreed to lower Medicaid prices and invest $100 billion in the US in exchange for tariff and pricing relief.",
      "url": "https://finnhub.io/api/news?id=e4ef8cd34086e88cd30402d138b3fc81c31b1f0708cc23371f7f454d9d73e900"
    }
  },
  {
    "ts": null,
    "headline": "1 Mooning  Stock with Exciting Potential and 2 Facing Headwinds",
    "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
    "url": "https://finnhub.io/api/news?id=e033e132fa4c1312bacd7ed9b37e6eb5d5eef19cde59e92158921a424c7e7ae5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768278908,
      "headline": "1 Mooning  Stock with Exciting Potential and 2 Facing Headwinds",
      "id": 138084615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
      "url": "https://finnhub.io/api/news?id=e033e132fa4c1312bacd7ed9b37e6eb5d5eef19cde59e92158921a424c7e7ae5"
    }
  }
]